首页|miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer

miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer

扫码查看
Dysregulation of microRNA(miRNA)expression in cancer is a significant factor contributing to the progression of chemoresistance.The objective of this study is to explore the underlying mechanisms by which miR-34b-3p reg-ulates chemoresistance in cervical cancer(CC).Previous findings have demonstrated low expression levels of miR-34b-3p in both CC chemoresistant cells and tissues.In this study,we initially characterize the behavior of SiHa/DDP cells which are CC cells resistant to the chemotherapeutic drug cisplatin(DDP).Subsequently,miR-34b-3p mimics are transfected into SiHa/DDP cells.It is observed that overexpression of miR-34b-3p substantially inhibits the proliferation,migration,and invasion abilities of SiHa/DDP cells and also enhances their sensitivity to DDP-induced cell death.Quantitative RT-PCR and western blot analysis further reveal elevated expression levels of STC2and FN1 in SiHa/DDP cells,contrary to the expression pattern of miR-34b-3p.Moreover,STC2 and FN1 contribute to DDP resistance,proliferation,migration,invasion,and decreased apoptosis in CC cells.Through dual-luciferase assay analysis,we confirm that STC2 and FN1 are direct targets of miR-34b-3p in CC.Finally,rescue experiments de-monstrate that overexpression of either STC2 or FN1 can partially reverse the inhibitory effects of miR-34b-3p overexpression on chemoresistance,proliferation,migration and invasion in CC cells.In conclusion,our findings support the role of miR-34b-3p as a tumor suppressor in CC.This study indicates that targeting the miR-34b-3p/STC2 or FN1 axis has potential therapeutic implications for overcoming chemoresistance in CC patients.

miR-34b-3pchemoresistancecervical cancerstanniocalcin 2(STC2)fibronectin 1(FN1)cisplatin

Shanshan Jin、Wenting Wang、Xinrui Xu、Zhaowei Yu、Zihan Feng、Jun Xie、Huimin Lv

展开 >

Department of Biochemistry and Molecular Biology,Shanxi Key Laboratory of Birth Defect and Cell Regeneration,Key Laboratory for Cellular Physiology of Ministry of Education,Shanxi Medical University,Taiyuan 030001,China

Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital,Third Hospital of Shanxi Medical University,Taiyuan 030032,China

Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China

Applied Basic Research Programs of Science and Technology Commission Foundation of Shanxi ProvinceScientific Research Project of Health Commission of Shanxi Province

202103021245922021151

2024

生物化学与生物物理学报(英文版)
中国科学院上海生物化学研究所

生物化学与生物物理学报(英文版)

CSTPCD
影响因子:0.772
ISSN:1672-9145
年,卷(期):2024.56(5)
  • 37